Investor Connect Podcast

Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing.

Just as you have an ideal customer profile, so you should have an ideal advisor profile.

Start with your industry and growth strategy and look for founders who have experience in the same.

Look for someone who has already gone through what you are going through now.

Start with those who are local and reach further out if necessary.

Once you’ve identified someone who meets the criteria, make contact with them.

Many founders will have some empathy for you since they know well the challenges you face.

Some will offer advice on the first call.

Parlay this budding relationship into a long-term advisor relationship.

In proposing the advisor role, minimize the time commitment and maximize the result.

Make clear to them their importance to you and your company.

Be prepared to pay something for it - most likely equity.

If the potential advisor doesn’t ask, then it’s best to bring it up for discussion.

Identify what the advisor thinks is most important and pursue that first.

Grow the relationship over time.

Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding.

Let’s go startup something today.

For more episodes from Investor Connect, please visit the site at: 

Check out our other podcasts here: 
For Investors check out: 
For Startups check out: 
For eGuides check out: 
For upcoming Events, check out 

For Feedback please contact  

Music courtesy of Bensound.

Direct download: Ideal_Advisors.mp3
Category:general -- posted at: 6:00am CDT

In this episode, Hall welcomes Robert Davidson, CEO of CURE Pharmaceutical.

CURE Pharmaceutical is an innovative drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and delivery systems. CURE has an industry-leading full-service cGMP manufacturing facility and is a preeminent developer and manufacturer of a patented and proprietary delivery system (CureFilm™), the most advanced oral thin film on the market today. CURE has developed an array of products in cutting-edge delivery platforms and partners with leading pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada, Israel and Germany, among other markets.

Prior to his role at CURE Pharmaceutical, Robert served as President and Chief Executive Officer of InnoZen Inc., Chief Executive Officer of Gel Tech LLC, Chief Executive Officer of Bio Delivery Technologies Inc., and has served on multiple corporate boards. Robert was responsible for the development of several drug delivery technologies and commercial brand extensions including the popular zinc product Zicam. He has worked with brands such as Chloraseptic™, Suppress™, as well as Pediastrip™, a private label electrolyte oral thin film sold in major drug store chains. He received his B.S. degree with a concentration in Biological Life Sciences and has a Masters Certificate in Applied Project Management from Villanova University, a Masters of Public Health from American Military University, Virginia, and a Masters in Health and Wellness from Liberty University, Virginia. Robert also completed his Post Graduate Studies at the University of Cambridge. 

Robert discusses the growth rate of the sector, the future of drug delivery, and some of the challenges he has faced. 

You can visit CURE Pharmaceutical at, via LinkedIn at, and via Twitter at

Robert can be contacted via LinkedIn at  

Music courtesy of Bensound.

Direct download: Robert_Davidson_of_CURE_Pharmaceutical.mp3
Category:general -- posted at: 6:00am CDT